Синий мочевой пузырь: врачи выявили, что фиолетовая окраска у катетеризированных пациентов не требует антибиотиков

A 75-year-old woman in hospice care had no fever, no pain, no burning, no change in her mental status. What she had was a catheter bag full of urine the color of deep indigo. Her hospice physician examined her, found nothing wrong, and ordered no tests. Two months later, the color was still there. A nursing home practitioner ordered a urinalysis, started an oral antibiotic, and sent a culture. Those culture results triggered a course of intramuscular ertapenem, a broad-spectrum carbapenem. The purple faded. A month after that it returned, and she got another carbapenem. Her doctors at Louisiana State University Health Sciences Center and Rapides Regional Medical Center used her case to ask an uncomfortable question, then went looking for the answer in 63 published cases. Their analysis in Cureus found the pattern was not unique to her at all. The Chemistry Behind the Color Purple urine bag syndrome is not a disease. It is a chemical reaction happening outside the body. Dietary tryptophan is broken down by gut bacteria into indoxyl sulfate, which is excreted in urine. In alkaline urine, bacterial enzymes convert it into two pigments, indigo and indirubin. Those pigments soak into the polyvinyl chloride of catheter tubing and collection bags, and the plastic turns purple. One detail in her case captures how misleading the whole thing is. When her urine was sent to the lab, it was reported as yellow. The purple only exists where the urine meets the plastic. The authors note this is a common finding in freshly collected samples. The organisms most associated with the color are Providencia and Proteus species. Established risk factors include an indwelling catheter, female sex, age 70 and older, being bedbound or institutionalized, constipation, chronic kidney disease, and diabetes. This patient had nearly all of them. What the 63 Cases Showed The authors pulled published case reports and series from the past decade and reclassified every patient using the Infectious Diseases Society of America symptom criteria for urinary tract infection, rather than accepting the original authors' conclusions. Only 15 of 63 patients, or 24 percent, met symptom-based criteria for a true urinary tract infection. The other 48, or 76 percent, had bacteria and abnormal urinalysis findings but none of the accepted signs of infection: no fever, no burning, no flank or pubic pain, no rigors, no sepsis. Every single case had an abnormal urinalysis. Ninety-four percent had a positive urine culture. And 52 patients, 83 percent of the total, received systemic antibiotics. Among the asymptomatic group specifically, 37 of 48 were treated, which is 77 percent. Nearly a quarter of all patients received broad-spectrum or intravenous therapy. The Number That Was Not There Three deaths occurred across the 63 cases, all in patients with established septic shock and critical illness. All three were correctly classified as symptomatic and appropriately treated with broad-spectrum antibiotics. The authors are explicit that purple urine bag syndrome itself was not implicated as the cause of sepsis in those cases, and that no asymptomatic case progressed to systemic infection. Their conclusion is that "PUBS more likely reflects underlying colonization in high-risk populations" rather than serving as an independent marker of disease. The index case contained its own quiet contradiction. Her culture grew high concentrations of extended-spectrum beta-lactamase-producing E. coli, which drove the choice of carbapenem. But the organisms that actually produce the purple pigment, Providencia stuartii and Proteus mirabilis, were present at much lower levels. The antibiotic was selected for a bug that probably had nothing to do with the color that prompted treatment. Why This Matters Beyond an Unusual Color Treating bacteria in urine without symptoms is one of the most common antibiotic prescribing errors in American medicine, and the Infectious Diseases Society of America has advised against it since its 2019 asymptomatic bacteriuria guideline. The downstream costs are established: resistance, adverse drug reactions, disrupted gut microbiota and Clostridioides difficile infection. The authors argue that most of the existing purple urine literature has pointed the other way. Reviewing earlier accounts, including one framing the syndrome as an alarming hue and a later clinical update, they found it repeatedly presented as a forerunner of severe infection, with bacteriuria, abnormal urinalysis, and the fading of the color after treatment offered as justification. Their objection is that the color resolved in most cases regardless of whether antibiotics were given, so resolution after treatment is not evidence that the treatment caused it. The hospice context sharpens the point. This patient received repeated painful intramuscular injections and was moved into isolation because of her culture results, both of which cut against the goal of comfort at the end of life. The analysis has real limits, and the authors say so. It draws on published case reports, which are prone to publication bias, since dramatic or treated cases get written up more often than conservatively managed ones. Data extraction was done by a single reviewer, the sample is small, and the statistics were exploratory rather than confirmatory. Their practical recommendation is unglamorous. Change the catheter, address constipation, look at the patient rather than the bag, and reserve antibiotics for people with actual symptoms of infection. Caregivers who notice discolored urine should report it to a clinician rather than assume either that it is harmless or that it demands treatment. Key Questions Answered What makes a urine bag turn purple? Gut bacteria convert dietary tryptophan into indoxyl sulfate, which is excreted in urine. In alkaline urine, bacterial enzymes turn it into the pigments indigo and indirubin. Those pigments stain the plastic of catheter tubing and bags. Is purple urine dangerous? The discoloration itself is not. It occurs almost entirely in elderly, chronically catheterized patients who already have bacteria in the urine. In this analysis, no asymptomatic case progressed to systemic infection. What did this analysis find about antibiotic use? Of 63 published cases, 76 percent had no accepted symptoms of urinary tract infection, yet 77 percent of those asymptomatic patients still received antibiotics. Overall, 83 percent of all patients were treated. When do antibiotics actually make sense? When the patient has symptoms defined by infectious disease guidance: fever, painful urination, urgency, pubic or flank pain, chills, rigors, or signs of sepsis. Abnormal urinalysis or a positive culture alone does not meet that bar. How reliable is this evidence? It is an aggregated review of published case reports, not a controlled study. The authors describe it as hypothesis-generating and flag publication bias, single reviewer data extraction, and a small sample as limitations. What should families of catheterized patients do? Report any unusual discoloration to the care team, but expect a symptom-based assessment rather than automatic antibiotics. Catheter exchange, hygiene, and treating constipation are the usual first steps. Published by Medicaldaily.com